Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

Dipak Kotecha, Katherine Ngo, Julia A E Walters, Luis Manzano, Alberto Palazzuoli, Marcus D Flather

Research output: Contribution to journalArticlepeer-review

58 Citations (Scopus)


Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.
Original languageEnglish
Pages (from-to)822-831.e2
JournalAmerican Heart Journal
Issue number5
Publication statusPublished - May 2011


  • Anemia
  • Erythropoietin
  • Heart Failure
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Cite this